Tauriga Sciences Inc. Announces the Arrival of Product Inventory for its Enhanced Tauri-Gum Product Line
Tauriga Sciences, Inc. (TAUG) has announced the arrival of product inventory for its enhanced Tauri-Gum™ line, featuring 11 SKUs available immediately on its e-commerce site. The enhanced product line includes various CBD and CBG flavored gum options, vital nutrient-infused variants, and collaborative products with Think Big, LLC. The company is preparing for a commercial launch to retail customers while continuing to develop a pharmaceutical-grade version aimed at nausea regulation for chemotherapy patients, following a patent application conversion.
- Launch of 11 SKUs in the enhanced Tauri-Gum™ product line.
- Immediate availability of products on Tauriga's e-commerce site.
- Focus on commercial launch to retail market, indicating growth potential.
- Development of a pharmaceutical-grade version of Tauri-Gum™ for nausea regulation.
- None.
NEW YORK, NY, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, has today announced the arrival of product inventory for its enhanced Tauri-Gum™ product line (11 SKUs in Total). This inventory is available, immediately, on the Company’s E-Commerce website (www.taurigum.com). Additionally, the Company is focused on the commercial launch (of its Enhanced Tauri-Gum™ Product Line) to the retail marketplace.
ENAHNCED Tauri-Gum™ CHEWING GUM PRODUCT LINE:
SKU # 1): 25mg CBD Mint Flavor
SKU # 2): 25mg CBD Blood Orange Flavor
SKU # 3): 25mg CBD Pomegranate Flavor
SKU # 4): 25mg CBG Black Currant Flavor
SKU # 5): 25mg CBG Peach-Lemon Flavor
SKU # 6): 10mg DELTA 8 THC Evergreen Mint Flavor
SKU # 7): 60mg Vitamin C + 10mg Zinc Pear Bellini Flavor
SKU # 8): 50mg Caffeine Cherry Lime Rickey Flavor
SKU # 9): 2,000 IU Vitamin D3 Golden Raspberry Flavor
PARTNERSHIP WITH THINK BIG, LLC (SKUs # 10 & 11)
SKU # 10): 15mg CBD + 10mg CBG + 5mg Vitamin C + 10mg Zinc Honey Lemon Flavor (Frank White/ Tauri-Gum™)
SKU #11): 25mg CBD Mint Flavor (Frank White/ Tauri-Gum™)
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant), (Vitamin C + Zinc Infused Tauri-Gum™ Flavor: Pear Bellini), (Caffeine Infused Tauri-Gum™ Flavor: Cherry Lime Rickey), & (Vitamin D3 Infused Tauri-Gum™ Flavor: Golden Raspberry). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com
Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative. This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 22, 2021, the Company announced that it had Converted its U.S. Provisional Patent Application (filed on March 17, 2020) into a U.S. Non-Provisional Patent Application. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts.
The Company is headquartered in Wappingers Falls, New York. In addition, the Company operates two full time E-Commerce fulfillment centers: one located in Montgomery, Texas and the other in Brooklyn, New York.
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other periodic filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.
Contact:
Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Company Instagram: @taurigum
Personal Instagram: @sethsms47
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
Attachment
FAQ
What new products has Tauriga Sciences (TAUG) announced?
Where can I purchase Tauriga's Tauri-Gum™ products?
What is the focus of Tauriga's pharmaceutical development?
What flavors are included in the enhanced Tauri-Gum™ product line?